Status:
ACTIVE_NOT_RECRUITING
Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
Lead Sponsor:
Eye Hospital Pristina Kosovo
Conditions:
Pseudophakia
Hypermetropia
Eligibility:
All Genders
19-50 years
Phase:
NA
Brief Summary
The residual hypermetropic refraction on pseudophakic(Trifocal IOL) patients is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with t...
Detailed Description
This study is to investigate the effect of fresh myopic corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant on pseudophakic patients(Trifocal IOL) wi...
Eligibility Criteria
Inclusion
- residual hypermetropic refraction on pseudophakic patients
- low visual acuity
Exclusion
- active anterior segment pathologic features,
- previous corneal or anterior segment surgery,
- glaucoma,
- retinal detachment
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2027
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04692012
Start Date
April 1 2018
End Date
February 1 2027
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Hospital Pristina
Pristina, Kosovo, 10000